000			01850 a2200517 4500
005			20250515233330.0
264		0	_c20101006
008			201010s 0 0 fre d
022			_a1769-6917
024	7		_a10.1684/bdc.2010.1155 _2doi
040			_aNLM _beng _cNLM
100	1		_aSouiden, Y
245	0	0	_a[Telomeres and telomerase as targeted therapies in cancer treatment]. _h[electronic resource]
260			_bBulletin du cancer _cSep 2010
300			_a1087-104 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aCell Division _xphysiology
650	0	4	_aCellular Senescence _xphysiology
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aForecasting
650	0	4	_aG-Quadruplexes
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aHumans
650	0	4	_aImmunotherapy _xmethods
650	0	4	_aNeoplasm Proteins _xphysiology
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOligonucleotides _xtherapeutic use
650	0	4	_aOligonucleotides, Antisense _xtherapeutic use
650	0	4	_aRNA
650	0	4	_aRNA Interference
650	0	4	_aRNA Processing, Post-Transcriptional
650	0	4	_aRNA, Catalytic _xtherapeutic use
650	0	4	_aRNA, Long Noncoding
650	0	4	_aRNA, Untranslated _xantagonists & inhibitors
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aTelomerase _xantagonists & inhibitors
650	0	4	_aTelomere _xchemistry
650	0	4	_aTelomeric Repeat Binding Protein 1 _xphysiology
650	0	4	_aTelomeric Repeat Binding Protein 2 _xphysiology
650	0	4	_aTranscription, Genetic
700	1		_aBouraoui, A
700	1		_aChaieb, K
700	1		_aMahdouani, K
773	0		_tBulletin du cancer _gvol. 97 _gno. 9 _gp. 1087-104
856	4	0	_uhttps://doi.org/10.1684/bdc.2010.1155 _zAvailable from publisher's website
999			_c20003733 _d20003733